The Role of Testosterone Supplemental Therapy in Opioid-Induced Hypogonadism: A Retrospective Pilot Analysis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Chronic opioid therapy for pain management is known to induce several endocrine changes. The authors examined the effect of testosterone supplemental therapy (TST) in patients with chronic, noncancer pain undergoing opioid therapy. It was hypothesized that treatment of opioid-induced hypogonadism (OIH) can reduce opioid requirements in patients suffering from chronic pain and approve their quality of life. Over 18 months period, patients with OIH were identified in a tertiary referral pain center, Numerical Rating Scale (NRS) pain scores and daily morphine equivalent dose (MED) were the primary outcomes measured. Data were collected and comparative analysis performed between men undergoing TST versus nontreatment group. Twenty-seven OIH patients (total testosterone <300 ng/dL) were identified during the study period. TST group consists of 11 patients, while non-TST group consists of 16 patients as control cohort. Mean patient age (55 and 54.4, p = .4) and basic metabolic index (28.5 and 31.9, p = .07) in TST and non-TST groups, respectively. Mean follow-up total testosterone (ng/dL) was significantly higher after TST compared with the non-TST group (497.5 vs. 242.4 ng/dL, p = .03). Median follow-up NRS was 0 and 2 in the TST and non-TST groups ( p = .02). Mean MED (mg) decreased by 21 mg in TST group and increased by 2.5 mg in non-TST group ( p < .05). This study reports that treatment of OIH with TST can reduce opioid requirements in men with chronic pain as quantified by MED. It also confirms previous reports on the potential effects of OIH and that TST is effective in correcting opioid-induced endocrine abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, R., Cappelleri, J., Smith, M., Lipsky, J., & Peña, B. (1999) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900472 · Cited by 3,053
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Clinical applications of visual analogue scales: a critical review
McCormack, H. M., de L. Horne, D. J., & Sheather, S. (1988) · Psychological Medicine · doi:10.1017/s0033291700009934 · Cited by 2,108
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954 · cited 1×
“Patients with symptomatic hypogonadism defined as TT less than 300 ng/dL as per the American Endocrine Society Clinical Practice Guidelines for male hypogonadism (Bhasin et al., 2010).”
BackgroundTrends in Opioid Analgesic–Prescribing Rates by Specialty, U.S., 2007–2012
Levy, B., Paulozzi, L., Mack, K. A., & Jones, C. M. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.02.020 · Cited by 723 · cited 3×
“…of patients presenting to physician offices with noncancer pain symptoms or pain-related diagnoses (including acute and chronic pain) receive an opioid prescription and about 10% have disabling chronic pain that limits work and family activities (Dowell, Haegerich, & Chou, 2016; Levy et al., 2015).”
BackgroundThe effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401 · cited 3×
“…suppression of the HPA axis is short-lived in patients who are not on chronic therapy, as it has been reported that Morphine can cause a reduction of the levels of testosterone as early as 4 hours, but this testosterone suppression reversed after 24 hours (Daniell, 2002; Rubinstein et al., 2013).”
BackgroundRole of interleukin-6 in chronic muscle hyperalgesic priming
Dina, O. A., Green, P. G., & Levine, J. D. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.006 · Cited by 164 · cited 1×
“In a study by Dina, Green, and Levine (2008), a panel of inflammatory cytokines has been evaluated and have shown that the presence of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) as inflammatory mediators produced during acute muscle inflammation, can mediate the production of…”
BackgroundOpen-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency
Daniell, H. W., Lentz, R., & Mazer, N. A. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.10.009 · Cited by 135
Opioid-Induced Androgen Deficiency (OPIAD)
Elliott, J. A. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es145 · Cited by 129
Research works printed but not linked: 1
- Smith H. S., 2012, Pain Physician, 15, ES145
Cited by
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Hackett, G. I., Kirby, M. G., Rees, R. W., Jones, T. H., Muneer, A., Livingston, M. A., Ossei‐Gerning, N., David, J., Foster, J., Kalra, P. A., et al. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.221027 · Cited by 107
“Certain medications may suppress testosterone levels, including oral glucocorticoids, opioids, anti-convulsants and antipsychotics [25-28] (see Table 1).”
Testosterone deficiency in non-cancer opioid-treated patients
Coluzzi, F., Billeci, D., Maggi, M., & Corona, G. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0964-3 · Cited by 81
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Sex Differences in Opioid-Mediated Effects: Role of Androgens
Sharp, J. L., Pearson, T., & Smith, M. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104522 · Cited by 72
Metadata
- Authors
- Raheem, O. A., Patel, S. H., Sisul, D., Furnish, T. J., & Hsieh, T.-C.
- Affiliations
- UC San Diego Health System (US)
- Center for Pain Medicine, University of California San Diego Health system, San Diego, CA, USA
- Corresponding author
- Hsieh, Tung-Chin
- Venue
- American Journal of Men's Health
- Publisher
- SAGE Publications
- Published
- 2016-10-07
- Volume
- 11
- Issue
- 4
- Pages
- 1208-1213
- ISSN
- 1557-9883 (ISSN-L)
- 1557-9891
- PMC
- PMC5675327
- OpenAlex
- W2528410242
- Semantic Scholar
- 1e5ae2fd0a865fada959f8d6493681168ef8a562
- Cited by
- 29
- References
- 17
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 5 · 2019: 8 · 2018: 5
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- American Journal of Men s Health (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- testosterone replacement therapy, chronic non-cancer pain, opioid requirement, morphine milligram equivalents, pain intensity, quality of life, men
- MeSH terms
- Analgesics, Opioid, Humans, Hypogonadism, Male, Middle Aged, Pain Measurement, Pilot Projects, Quality of Life, Retrospective Studies, Testosterone, Treatment Outcome, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Testosterone Supplemental Therapy in Opioid-Induced Hypogonadism: A Retrospective Pilot Analysis. https://app.cochat.ai/papers/10.1177/1557988316672396
- The paper
- Raheem, O. A., Patel, S. H., Sisul, D., Furnish, T. J., & Hsieh, T.-C. (2017). The Role of Testosterone Supplemental Therapy in Opioid-Induced Hypogonadism: A Retrospective Pilot Analysis. American Journal of Men's Health. https://doi.org/10.1177/1557988316672396
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.